Nicox Provides Fourth Quarter 2022 Financial Highlights

Press ReleaseNicox Provides Fourth Quarter 2022 Financial Highlights Net revenue €1.0 million for fourth quarter 2022, and €3.3 million for the full year 2022; cash of €27.7 million on December

Related Keywords

China ,Valbonne ,Provence Alpes Côd Azur ,France ,Paris ,France General ,United Kingdom ,Chinese ,Gavin Spencer ,Kepler Cheuvreux Arsene Guekam ,Pharma Bio ,States Europe ,Sophia Antipolis ,Santen Pharmaceutical Co Ltd ,Bloomberg ,Nicox Group ,Lifesci Advisors ,Head Of Corporate Development ,Garnier Co Eric Yoo Paris ,Eyevance Pharmaceuticals ,Edison Investment Research Pooya Hemami London ,Provides Fourth Quarter ,Euronext Paris ,Ocumension Therapeutics ,Kreos Capital ,French State ,Southeast Asian ,Mid Caps ,Eric Yoo ,Investment Research ,Pooya Hemami ,New York ,Arsene Guekam ,Vice President ,Chief Business ,Corporate Development ,Sci Advisors ,French Autorit ,Des March ,Nicox ,Rovides ,Fourth ,Quarter ,022 ,Financial ,Highlights ,